Voyager Therapeutics Company
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Total Funding:
135000000
Investor Type:
Company
Technology:
Neurological Disorders
Investment Stage:
N/A
Last Funding Type:
Series B
Estimated Revenue:
$10M to $50M
Founded Date:
01 01 13
Industry:
Biotechnology, Health Care, Science and Engineering
Employee Number:
101-250
Last Funding Date:
13 04 15
Funding Status:
IPO
Number Of Exists:
Series B
Headquarters:
Cambridge, Massachusetts, United States
Investors Number:
7